Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Saurabh Gupta

Interventional Cardiology Bend, OR Medical Doctor

NPI 1902873177 CMS profile 268373

2500 Ne Neff Road, Bend, OR 97701

Open in the dashboard

General payments

$549,544

623 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$250 paid to institutions, not to them · program year 2022

Through program year 2025, Saurabh Gupta of Bend, OR is reported in the CMS Open Payments database as having received $549,544 across 623 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $250 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Interventional Cardiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $92,401 98
2024 General $70,130 115
2023 General $124,267 130
2022 General $34,639 63
2021 General $16,587 50
2020 General $75,610 51
2019 General $135,911 116

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Saurabh Gupta
  • Interventional Cardiology median
  • Middle half of Interventional Cardiology
  • National median

In program year 2025, general payments to Saurabh Gupta were reported at $92,401. Among 6,173 Interventional Cardiology profiles paid that year, the median was $1,092 and the middle half received between $366 and $3,019.

Show as a table
Year Saurabh Gupta Interventional Cardiology median Middle half National median
2019 $135,911 $1,097 $329–$3,048 $163
2020 $75,610 $473 $161–$1,480 $114
2021 $16,587 $677 $233–$1,827 $132
2022 $34,639 $978 $333–$2,724 $149
2023 $124,267 $1,136 $382–$2,986 $160
2024 $70,130 $1,181 $395–$3,326 $164
2025 $92,401 $1,092 $366–$3,019 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $313,702 307 payments
  2. Medtronic Vascular, Inc. $170,950 122 payments
  3. Edwards Lifesciences Corporation $58,291 76 payments
  4. Abbott Laboratories $3,105 40 payments
  5. Boston Scientific Corporation $2,625 64 payments
  6. Abiomed $435 4 payments
  7. Cook Medical LLC $228 4 payments
  8. Philips Electronics North America Corporation $121 1 payment
  9. Shockwave Medical, Inc $36 2 payments
  10. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $19 1 payment
  11. Other $33 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $387,775 86 payments
  2. Travel and Lodging $90,506 196 payments
  3. Consulting Fee $46,488 8 payments
  4. Food and Beverage $18,432 331 payments
  5. Honoraria $6,344 2 payments
Products named General payments · program years 2019–2025
  1. COREVALVE EVOLUT R $301,751 272 payments
  2. CoreValve Evolut Transcatheter Valve Systems $170,616 118 payments
  3. Edwards SAPIEN 3 Transcatheter Heart Valve $23,805 14 payments
  4. EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) $14,400 8 payments
  5. CoreValve Evolut Transcatheter Valve Systems $9,644 22 payments
  6. Edwards SAPIEN XT Transcatheter Heart Valve $3,172 1 payment
  7. EVOQUE $1,937 15 payments
  8. PASCAL $1,698 12 payments
  9. AMPLATZER Occluders $1,534 15 payments
  10. WATCHMAN $1,180 7 payments
  11. Other $5,023 109 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

15

Median for Interventional Cardiology: 2,236

Drug cost

$131

Median for Interventional Cardiology: $380,412

Branded share of claims

100%

Median for Interventional Cardiology: 27.8%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Clopidogrel Clopidogrel Bisulfate Brand 15 $131

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 4,694 Part D prescribers listed as Interventional Cardiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 47 billing codes

Paid by Medicare

$138,974

Medicare's payments for the services billed

Medicare patients

274

Average age 77

Services billed

862

112 women, 162 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Heart failure 66%
Ischemic heart disease 65%
Atrial fibrillation 64%
Arthritis 57%
Chronic kidney disease 30%
Depression 28%
Diabetes 26%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

623 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record